Rita M O'Connor insider trades: PLx Pharma (PLXP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rita reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 15, 2022 | PLXP | ↑ Buy | 13,700 | $3.66 | $50K | Direct | Mar 16, 2022 (1d) |
| Sep 2, 2020 | PLXP | ↑ Buy | 6,620 | $3.77 | $25K | Direct | Sep 3, 2020 (1d) |
| Aug 21, 2020 | PLXP | ↑ Buy | 6,350 | $3.90 | $25K | Direct | Aug 24, 2020 (3d) |
| Nov 8, 2007 | ARXT | ↓ Sell | 4,212 | $43.49 | $183K | Direct | Nov 8, 2007 (0d) |
| Aug 20, 2007 | ARXT | ↓ Sell | 1,653 | $40.52 | $67K | Direct | Aug 22, 2007 (2d) |
| Jul 24, 2007 | ARXT | ↓ Sell | 2,400 | $40.00 | $96K | Direct | Jul 25, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rita M O'Connor's insider trades
Rita M O'Connor is Chief Financial Officer at PLx Pharma (PLXP). Since Jul 24, 2007, Rita has reported 3 open-market purchases worth $100K and 3 sales worth $346K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), option exercises (3 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.